Open AccessCovid - 19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients : A Case Report
Author(s) -
Himadri Dutta Vandana Sinha,
Anup Jyoti Dutta Pinku Sarma
Publication year - 2021
Publication title -
international journal of current microbiology and applied sciences
Language(s) - English
Resource type - Journals
eISSN - 2319-7706
pISSN - 2319-7692
DOI - 10.20546/ijcmas.2021.1009.046
Subject(s) - medicine , incidence (geometry) , pneumonia , covid-19 , aspergillosis , intensive care medicine , pulmonary aspergillosis , intensive care , critically ill , pulmonary infection , infectious disease (medical specialty) , immunology , disease , physics , optics
In the present study report three cases of covid-19 associated Pulmonary Aspergillosis from covid ICU of a private hospital. There is increased incidence of different co infections including fungal from severe cases of covid-19 requiring ICU care from different parts of the world. None of the patients in our report had any predisposing lung conditions and none of them were on long term steroids treatment. Out of the three cases, two cases clinically improved dramatically after initiation of antifungals. Second case deteriorated even before culture diagnosis was established and the patient died before antifungals could be started. So, possibility of a fungal infection should be always ruled out in all COVID-19 pneumonia cases without any clinical improvement after standard treatment and intensive care. Early diagnosis and treatment will help improve clinical outcomes in such cases.